179321-49-4

Basic information

• Product Name: 4-N-Boc-aminocyclohexanone
• Synonyms: BOC-4-AMINOCYCLOHEXANONE;(4-OXO-CYCLOHEXYL)-CARBAMIC ACID TERT-BUTYL ESTER;4-N-BOC-AMINOCYCLOHEXANONE;4-N-BOC-4-AMINOCYCLOHEXANONE;4-AMINOCYCLOHEXANONE N-BOC PROTECTED;N-4-BOC-AMINOCYCLOHEXANONE;N-T-BOC-4-AMINOCYCLOHEXANONE;TERT-BUTYL 4-OXOCYCLOHEXYLCARBAMATE
• CAS NO: 179321-49-4
• Molecular Formula: C₁₁H₁₉NO₃
• Molecular Weight: 213.27
• EINECS: 1806241-263-5
• Product Categories: N-BOC;Amines;blocks;Acids and Derivatives;Carbonyl Compounds;pharmacetical;CHIRAL CHEMICALS;Building Blocks;C10 to C11;C11 to C12;Chemical Synthesis;Ethers;New Products for Chemical Synthesis;Nitrogen Compounds;Organic Building Blocks;Oxygen Compounds
• Mol File: 179321-49-4.mol
• Article Data: 23

Chemical Properties

• Melting Point: 114-118℃
• Boiling Point: 335.9 °C at 760 mmHg
• Flash Point: 157 °C
• Appearance: /
• Density: 1.06 g/cm³
• Vapor Pressure: 0.000116mmHg at 25°C
• Refractive Index: 1.474
• Storage Temp.: 2-8°C
• Solubility: soluble in Methanol
• PKA: 12.19±0.20(Predicted)
• CAS DataBase Reference: 4-N-Boc-aminocyclohexanone(CAS DataBase Reference)
• NIST Chemistry Reference: 4-N-Boc-aminocyclohexanone(179321-49-4)
• EPA Substance Registry System: 4-N-Boc-aminocyclohexanone(179321-49-4)

Safety Data

• Hazard Codes: Xi,N
• Statements: 36/37/38-50
• Safety Statements: 26-36/37/39-61
• RIDADR: UN 3077 9 / PGIII
• WGK Germany: 3
• Hazardous Substances Data: 179321-49-4(Hazardous Substances Data)

Usage

General Description

4-N-Boc-aminocyclohexanone is a chemical compound with the molecular formula C13H23NO3. It is a derivative of cyclohexanone, with a Boc-protected amino group attached to the fourth carbon atom. 4-N-Boc-aminocyclohexanone is commonly used in the synthesis of pharmaceuticals and organic compounds. The Boc protecting group is often employed to prevent unwanted reactions with the amino group during chemical transformations, allowing for selective modification of the molecule. 4-N-Boc-aminocyclohexanone has been used in the synthesis of various bioactive compounds, making it a valuable intermediate in organic chemistry.

InChI:InChI=1/C11H19NO3/c1-11(2,3)15-10(14)12-8-4-6-9(13)7-5-8/h8H,4-7H2,1-3H3,(H,12,14)

Upstream product

• 111300-06-2 trans-tert-butyl 4-hydroxycyclohexylcarbamate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 27489-62-9 trans-4-hydroxycyclohexylamine 
• 50910-54-8 trans-4-aminocyclohexanol hydrochloride 
• 224309-64-2 tert-butyl N-(4-hydroxycyclohexyl)carbamate 
• 79-37-8 oxalyl dichloride 
• 114615-82-6 tetrapropylammonium perruthennate 
• 7529-22-8 4-methylmorpholine N-oxide 
• 6850-65-3 p-hydroxycyclohexylamine 
• 87413-09-0 Dess-Martin periodane 
• 87976-86-1 4‐aminocyclohexanone 
• 34619-03-9 tert-butyldicarbonate 
• 27489-62-9 trans-4-aminocyclohexan-1-ol 

Downstream Products

• 503817-60-5 3-(4-t-butoxycarbonylaminocyclohexylidene)-1-tetrahydropyranyloxypropane 
• 725255-70-9 tert-butyl (4-methylenecyclohexyl)carbamate 
• 868528-95-4 4-(N,N-bis(tert-butoxycarbonyl)amino)cyclohexanone 
• 886206-08-2 {4-[4-(2-isopropoxy-phenyl)-piperazin-1-yl]-cyclohexyl}-carbamic acid tert-butyl ester 
• 1001414-20-5 tert-butyl N-[4-(1H-pyrrolo[2,3-b]pyridin-3-yl)cyclohex-3-en-1-yl]carbamate 
• 1013921-23-7 C₂HF₃O₂*C₆H₁₁NO 
• 1171130-67-8 (3-dimethylaminomethylene-4-oxo-cyclohexyl)-carbamic acid tert-butyl ester 
• 910605-31-1 {4-[4-(2-cyclopropoxy-phenyl)-piperidin-1-yl]-cyclohexyl}-carbamic acid tert-butyl ester 
• 910605-45-7 (4-{4-[2-(2,2,2-trifluoro-ethoxy)-phenyl]-piperidin-1-yl}-cyclohexyl)-carbamic acid tert-butyl ester 
• 946605-78-3 C₂₄H₃₇FN₂O₃ 
• 946605-79-4 C₂₄H₃₆F₂N₂O₃ 
• 910605-67-3 {4-[4-(4-fluoro-2-isopropoxy-phenyl)-piperidin-1-yl]-cyclohexyl}-carbamic acid tert-butyl ester 
• 946605-80-7 C₂₅H₃₉FN₂O₃ 
• 886206-13-9 C₂₃H₃₄F₃N₃O₃ 

Relevant articles and documents

Iridinesulfonamide compound and use method thereof

An iridinesulfonamide compound having isocitrate dehydrogenase 1 (IDH1) inhibitory activity, pharmaceutically-acceptable salts, solvates or hydrates thereof, a pharmaceutical composition, as well as use of the compound or the pharmaceutically-acceptable salts, solvates or hydrates thereof, and the pharmaceutical composition thereof in treating IDH1 mutation-induced cancers.

FeCl3·6H2O/acetaldehyde, a versatile system for the deprotection of ketals and acetals via a transacetalization process

Mild and efficient catalytic deprotection of ketals/acetals mediated by FeCl3·6H2O/acetaldehyde has been described in this paper. The versatility and high chemoselectivity of the iron(iii)/aldehyde system are demonstrated by a large scope of examples. Deprotected ketones/aldehydes are nearly quantitatively isolated after filtration over a pad of silica gel followed by evaporation of volatile by-products.

THERAPEUTICALLY ACTIVE COMPOUNDS AND USE THEREOF

Provided are therapeutically active compounds and the use in manufacture of medicaments for treating a cancer characterized by the presence of a mutant allele of IDH1.